Co-localization of crotamine with internal membranes and accentuated accumulation in tumor cells
Registo de metadados completa
Campo DC | Valor | idioma |
---|---|---|
dc.contributor | (LG) Lab. Genética | pt_BR |
dc.contributor | (LDI) Lab. Desenvolvimento e Inovação Industrial | pt_BR |
dc.contributor.author | Mambelli, Nicole Caroline | pt_BR |
dc.contributor.author | Sciani, Juliana Mozer | pt_BR |
dc.contributor.author | Prieto da Silva, Álvaro Rossan de Brandão | pt_BR |
dc.contributor.author | Kerkis, Irina | pt_BR |
dc.date.accessioned | 2020-07-09T21:20:23Z | - |
dc.date.available | 2020-07-09T21:20:23Z | - |
dc.date.issued | 2018 | pt_BR |
dc.identifier.citation | Mambelli NC, Sciani JM, Prieto da Silva ARB, Kerkis I. Co-localization of crotamine with internal membranes and accentuated accumulation in tumor cells. Molecules. 2018 Apr;23(4):968. doi:10.3390/molecules23040968. | pt_BR |
dc.identifier.uri | https://repositorio.butantan.gov.br/handle/butantan/2489 | - |
dc.description.abstract | Crotamine is a highly cationic; cysteine rich, cross-linked, low molecular mass cell penetrating peptide (CPP) from the venom of the South American rattlesnake. Potential application of crotamine in biomedicine may require its large-scale purification. To overcome difficulties related with the purification of natural crotamine (nCrot) we aimed in the present study to synthesize and characterize a crotamine analog (sCrot) as well investigate its CPP activity. Mass spectrometry analysis demonstrates that sCrot and nCrot have equal molecular mass and biological function-the capacity to induce spastic paralysis in the hind limbs in mice. sCrot CPP activity was evaluated in a wide range of tumor and non-tumor cell tests performed at different time points. We demonstrate that sCrot-Cy3 showed distinct co-localization patterns with intracellular membranes inside the tumor and non-tumor cells. Time-lapse microscopy and quantification of sCrot-Cy3 fluorescence signalss in living tumor versus non-tumor cells revealed a significant statistical difference in the fluorescence intensity observed in tumor cells. These data suggest a possible use of sCrot as a molecular probe for tumor cells, as well as, for the selective delivery of anticancer molecules into these tumors. | pt_BR |
dc.description.sponsorship | (FAPESP) Fundação de Amparo à Pesquisa do Estado de São Paulo | pt_BR |
dc.description.sponsorship | (GSK) GlaxoSmithKline | pt_BR |
dc.format.extent | 968 | pt_BR |
dc.language.iso | English | pt_BR |
dc.relation.ispartof | Molecules | pt_BR |
dc.rights | Open access | pt_BR |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | pt_BR |
dc.title | Co-localization of crotamine with internal membranes and accentuated accumulation in tumor cells | pt_BR |
dc.type | Article | pt_BR |
dc.rights.license | CC BY | pt_BR |
dc.identifier.doi | 10.3390/molecules23040968 | pt_BR |
dc.identifier.url | http://dx.doi.org/10.3390/molecules23040968 | pt_BR |
dc.identifier.citationvolume | 23 | pt_BR |
dc.identifier.citationissue | 4 | pt_BR |
dc.subject.keyword | co-localization | pt_BR |
dc.subject.keyword | molecular imaging | pt_BR |
dc.subject.keyword | membrane trafficking | pt_BR |
dc.subject.keyword | cell penetrating peptide (CPP) | pt_BR |
dc.subject.keyword | crotamine | pt_BR |
dc.subject.keyword | tumor marker | pt_BR |
dc.relation.ispartofabbreviated | Molecules | pt_BR |
dc.identifier.citationabnt | v. 23, n. 4, 968, abr. 2018 | pt_BR |
dc.identifier.citationvancouver | 2018 Apr;23(4):968 | pt_BR |
dc.contributor.butantan | Prieto da Silva, Álvaro Rossan de Brandão|:Pesquisador|:Lab. Genética|: | pt_BR |
dc.contributor.butantan | Mambelli, Nicole Caroline|:Aluno|:Lab. Genética|:PrimeiroAutor:Autor de correspondência | pt_BR |
dc.contributor.butantan | Sciani, Juliana Mozer|:Técnico:Docente Colaborador PPGTOX|:Lab. Biologia Molecular|: | pt_BR |
dc.contributor.butantan | Kerkis, Irina|:Pesquisador:Docente Permanente PPGTOX|:Lab. Genética|: | pt_BR |
dc.sponsorship.butantan | Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)¦¦ | pt_BR |
dc.sponsorship.butantan | GlaxoSmithKline (GSK)¦¦2015/50040-4 | pt_BR |
dc.identifier.bvscc | BR78.1 | pt_BR |
dc.identifier.bvsdb | IBProd | pt_BR |
dc.description.dbindexed | Yes | pt_BR |
item.fulltext | Com Texto completo | - |
item.openairetype | Article | - |
item.languageiso639-1 | English | - |
item.grantfulltext | open | - |
crisitem.author.dept | #PLACEHOLDER_PARENT_METADATA_VALUE# | - |
crisitem.author.dept | #PLACEHOLDER_PARENT_METADATA_VALUE# | - |
crisitem.author.dept | #PLACEHOLDER_PARENT_METADATA_VALUE# | - |
crisitem.author.dept | #PLACEHOLDER_PARENT_METADATA_VALUE# | - |
crisitem.author.orcid | #PLACEHOLDER_PARENT_METADATA_VALUE# | - |
crisitem.author.orcid | 0000-0001-7213-206X | - |
crisitem.author.orcid | 0000-0003-0289-9809 | - |
crisitem.author.orcid | 0000-0003-4433-7580 | - |
crisitem.journal.journalissn | #PLACEHOLDER_PARENT_METADATA_VALUE# | - |
crisitem.journal.journaleissn | #PLACEHOLDER_PARENT_METADATA_VALUE# | - |
Aparece nas Coleções: | Artigos |
Arquivos neste item
Este item está licenciada sob uma Licença Creative Commons